- RecruitingPHASE2
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
This study is testing a new medicine, Claseprubart, for adults with Multifocal Motor Neuropathy (MMN). We want to see if it's safe, how it works in the body, and if it can help improve symptoms. Participants will receive either the new medicine or a placebo.
For: Multifocal Motor NeuropathyUnited States · Canada · China - Active not recruitingPHASE2
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
This study is testing a new medicine, Claseprubart (also called DNTH103), for adults with a condition called generalized myasthenia gravis (gMG). We want to see if the medicine is safe, well-tolerated, and helps improve symptoms. Some people will get the new medicine, and others a placebo.
For: Myasthenia Gravis, GeneralizedUnited States · Argentina · Canada - RecruitingPHASE3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
This study looks at a new drug, claseprubart, for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). It aims to see if the drug helps people with CIDP and if it's safe. Some participants will receive the drug, and others a dummy treatment.
For: Chronic Inflammatory Demyelinating PolyneuropathyUnited States · Argentina · Australia